A detailed history of James Investment Research Inc transactions in Johnson & Johnson stock. As of the latest transaction made, James Investment Research Inc holds 40,985 shares of JNJ stock, worth $6.36 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
40,985
Previous 42,059 2.55%
Holding current value
$6.36 Million
Previous $6.15 Million 8.05%
% of portfolio
0.78%
Previous 0.74%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$145.48 - $167.38 $156,245 - $179,766
-1,074 Reduced 2.55%
40,985 $6.64 Million
Q2 2024

Jul 30, 2024

SELL
$144.38 - $157.78 $567,702 - $620,390
-3,932 Reduced 8.55%
42,059 $6.15 Million
Q1 2024

May 01, 2024

SELL
$155.22 - $162.74 $265,426 - $278,285
-1,710 Reduced 3.58%
45,991 $7.28 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $422,094 - $460,593
-2,899 Reduced 5.73%
47,701 $7.48 Million
Q3 2023

Oct 31, 2023

SELL
$155.75 - $174.48 $74,604 - $83,575
-479 Reduced 0.94%
50,600 $7.88 Million
Q2 2023

Aug 07, 2023

SELL
$154.35 - $166.11 $186,609 - $200,826
-1,209 Reduced 2.31%
51,079 $8.45 Million
Q1 2023

Apr 25, 2023

BUY
$151.05 - $180.26 $36,252 - $43,262
240 Added 0.46%
52,288 $8.11 Million
Q4 2022

Jan 30, 2023

SELL
$160.2 - $179.79 $327,128 - $367,131
-2,042 Reduced 3.78%
52,048 $9.19 Million
Q3 2022

Oct 31, 2022

SELL
$161.33 - $179.52 $239,091 - $266,048
-1,482 Reduced 2.67%
54,090 $8.84 Million
Q2 2022

Aug 01, 2022

SELL
$168.19 - $186.01 $74,508 - $82,402
-443 Reduced 0.79%
55,572 $9.87 Million
Q1 2022

Apr 22, 2022

SELL
$158.14 - $179.59 $1.52 Million - $1.73 Million
-9,641 Reduced 14.68%
56,015 $9.93 Million
Q4 2021

Jan 28, 2022

SELL
$155.93 - $173.01 $380,469 - $422,144
-2,440 Reduced 3.58%
65,656 $11.2 Million
Q3 2021

Oct 22, 2021

SELL
$161.5 - $179.47 $45,058 - $50,072
-279 Reduced 0.41%
68,096 $11 Million
Q2 2021

Jul 26, 2021

SELL
$159.48 - $171.07 $197,914 - $212,297
-1,241 Reduced 1.78%
68,375 $11.3 Million
Q1 2021

Apr 22, 2021

SELL
$153.07 - $170.48 $3.43 Million - $3.82 Million
-22,384 Reduced 24.33%
69,616 $11.4 Million
Q4 2020

Jan 27, 2021

SELL
$137.11 - $157.38 $646,199 - $741,731
-4,713 Reduced 4.87%
92,000 $14.5 Million
Q3 2020

Oct 23, 2020

BUY
$140.38 - $153.83 $3.74 Million - $4.1 Million
26,642 Added 38.02%
96,713 $14.4 Million
Q2 2020

Jul 24, 2020

BUY
$128.81 - $155.51 $207,255 - $250,215
1,609 Added 2.35%
70,071 $9.85 Million
Q1 2020

Apr 22, 2020

SELL
$111.14 - $153.99 $585,374 - $811,065
-5,267 Reduced 7.14%
68,462 $8.98 Million
Q4 2019

Jan 24, 2020

BUY
$127.5 - $146.44 $39,780 - $45,689
312 Added 0.42%
73,729 $10.8 Million
Q3 2019

Oct 30, 2019

SELL
$126.95 - $142.14 $778,203 - $871,318
-6,130 Reduced 7.71%
73,417 $9.5 Million
Q2 2019

Jul 24, 2019

BUY
$131.15 - $144.24 $10.4 Million - $11.4 Million
79,125 Added 18750.0%
79,547 $11.1 Million
Q1 2019

Apr 26, 2019

BUY
$125.72 - $139.79 $7,920 - $8,806
63 Added 17.55%
422 $59,000
Q4 2018

Jan 22, 2019

BUY
$122.84 - $147.84 $3,316 - $3,991
27 Added 8.13%
359 $46,000
Q4 2017

Jan 23, 2018

SELL
$131.22 - $143.62 $9,972 - $10,915
-76 Reduced 18.63%
332 $46,000
Q3 2017

Oct 13, 2017

BUY
$129.47 - $135.38 $52,823 - $55,235
408
408 $53,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.